International ELBCC ILC Symposium 2022

The International ILC Symposium 2022 was hosted in Utrecht the Nederlands this week, June 2022.

The European Lobular Breast Cancer Consortium is supported by European Cost Action #CA19138 #Lobsterpot bringing together Scientific Experts from all ILC Breast Cancer disciplines, Clinical, Surgical, Oncology, Pathology, Histopathology, who collaborate and share their knowledge to promote further partnerships to ensure that Invasive Lobular Breast Cancer Patients are not left behind.

The breast cancer subtypes invasive lobular carcinoma and ductal carcinoma are often grouped. Dr. Jason Mouabbi explains why invasive lobular carcinoma should be studied separately. This is a fantastic article written by Devon Carter

We have a huge amount of Information to disseminate following the #ILCSymposium but we thought you might to see some photos from our coverage of the event.

Prof Steffi Oesterreich Key Note Speaker 1
Prof Sabine Linn Key Note Speaker Day 2
End of a fantastic #ILCSymposium Tone Lien, Siobhán Freeney and Esther Gevan European Patient Advocates with Professor Sabine Linn Nederlands Cancer Institute

Prof Steffi Oesterreich with Dr Jason Mouabbi and ELBCC Patient Advocate Siobhán Freeney
Two very tired but very happy women Professor Cathrin Brisken Ecole polytechnique fédérale de Lausanne EPFL and Lobular Ireland Founder Siobhán Freeney
Smiles all round Dr Christine Desmedt, Gabrielle Beck, Siobhán Freeney, Prof Patrick Derksen, Tone Lien, Dr Anne Vincent-Salomon, Dr Rita Mukhtar
Karen Van Baelan MD and David Lim are both recipients of the Conquer Cancer ILC research Award for Young Investigators
Chairman of The #ILCSymposium2022 Professor Patrick Derksen UMC Utrecht

We’ll bring you lots more details soon #LivingWithLobular

%d bloggers like this: